ESC 365 - Why is it important to treat symptomatic heart failure patients?

ESC Premium Access

Why is it important to treat symptomatic heart failure patients?

Session: Could neuromodulation via the baroreflex work in heart failure after all?

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor J. Cleland (Glasgow, GB)

Sponsored by CVRx Inc

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

82 presentations

13 followers

4 more presentations in this session

The role of the baroreflex in heart failure with a reduced ejection fraction

Speaker: Professor A. Stewart Coats (Sydney, AU)

Baroreflex activation therapy: mechanism of action and early results in heart failure

Speaker: Doctor E. Gronda (Sesto S. Giovanni, IT)

Latest BAT results in heart failure: the 6-month data of BEAT-HF study

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

BiRD-HF study and future perspective on BAT use

Speaker: Professor J. Bauersachs (Hannover, DE)

Access the full session

Could neuromodulation via the baroreflex work in heart failure after all?

Speakers: Professor J. Cleland, Professor A. Stewart Coats, Doctor E. Gronda, Professor F. Zannad, Professor J. Bauersachs

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources